Rank | Gene Set | Z-score |
---|---|---|
1 | axonemal dynein complex assembly (GO:0070286) | 5.26219321 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.14315413 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77693936 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77693936 |
5 | low-density lipoprotein particle remodeling (GO:0034374) | 4.60206393 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59099619 |
7 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.57367665 |
8 | regulation of metalloenzyme activity (GO:0048552) | 4.29645445 |
9 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.23110471 |
10 | hypotonic response (GO:0006971) | 4.10448240 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.91196993 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.80909221 |
13 | blood coagulation, intrinsic pathway (GO:0007597) | 3.71815961 |
14 | pinocytosis (GO:0006907) | 3.67639308 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67069469 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67069469 |
17 | modulation by symbiont of host immune response (GO:0052553) | 3.67069469 |
18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67069469 |
19 | modulation by symbiont of host defense response (GO:0052031) | 3.67069469 |
20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67069469 |
21 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65816948 |
22 | positive regulation of blood coagulation (GO:0030194) | 3.53385919 |
23 | positive regulation of hemostasis (GO:1900048) | 3.53385919 |
24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53327168 |
25 | motile cilium assembly (GO:0044458) | 3.52662843 |
26 | regulation of macrophage chemotaxis (GO:0010758) | 3.52041333 |
27 | definitive hemopoiesis (GO:0060216) | 3.50609251 |
28 | regulation of platelet activation (GO:0010543) | 3.44301666 |
29 | negative regulation of platelet activation (GO:0010544) | 3.41266936 |
30 | platelet degranulation (GO:0002576) | 3.40039510 |
31 | cilium movement (GO:0003341) | 3.39301069 |
32 | angiogenesis involved in wound healing (GO:0060055) | 3.36297340 |
33 | regulation of apoptotic cell clearance (GO:2000425) | 3.35961547 |
34 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.35407966 |
35 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.30936256 |
36 | cellular extravasation (GO:0045123) | 3.30630024 |
37 | positive regulation of coagulation (GO:0050820) | 3.28983772 |
38 | positive regulation of B cell differentiation (GO:0045579) | 3.25224360 |
39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.24410147 |
40 | endothelium development (GO:0003158) | 3.23325698 |
41 | lipoxygenase pathway (GO:0019372) | 3.19890825 |
42 | negative regulation of granulocyte differentiation (GO:0030853) | 3.19037283 |
43 | regulation of cholesterol esterification (GO:0010872) | 3.18846564 |
44 | plasma lipoprotein particle assembly (GO:0034377) | 3.17679279 |
45 | fibrinolysis (GO:0042730) | 3.16899068 |
46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16358864 |
47 | glycosphingolipid catabolic process (GO:0046479) | 3.12460114 |
48 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.10918695 |
49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.10165583 |
50 | oligosaccharide catabolic process (GO:0009313) | 3.10121451 |
51 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.09686075 |
52 | negative regulation of protein localization to cell surface (GO:2000009) | 3.09569231 |
53 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.07549015 |
54 | negative regulation of humoral immune response (GO:0002921) | 3.06295982 |
55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05372145 |
56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05358719 |
57 | negative regulation of norepinephrine secretion (GO:0010700) | 3.03910355 |
58 | barbed-end actin filament capping (GO:0051016) | 3.03697177 |
59 | reverse cholesterol transport (GO:0043691) | 3.03235520 |
60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01389568 |
61 | membrane raft organization (GO:0031579) | 2.99985120 |
62 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.99939821 |
63 | glycolipid catabolic process (GO:0019377) | 2.99491102 |
64 | platelet aggregation (GO:0070527) | 2.99033722 |
65 | protein-lipid complex assembly (GO:0065005) | 2.97986470 |
66 | negative regulation of blood coagulation (GO:0030195) | 2.97254809 |
67 | negative regulation of hemostasis (GO:1900047) | 2.97254809 |
68 | negative regulation of coagulation (GO:0050819) | 2.97197978 |
69 | regulation of cholesterol storage (GO:0010885) | 2.95384266 |
70 | plasma lipoprotein particle remodeling (GO:0034369) | 2.94571068 |
71 | protein-lipid complex remodeling (GO:0034368) | 2.94571068 |
72 | macromolecular complex remodeling (GO:0034367) | 2.94571068 |
73 | positive regulation of extracellular matrix organization (GO:1903055) | 2.92911834 |
74 | regulation of platelet aggregation (GO:0090330) | 2.92882364 |
75 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.92449894 |
76 | immunoglobulin mediated immune response (GO:0016064) | 2.91048846 |
77 | response to xenobiotic stimulus (GO:0009410) | 2.90751571 |
78 | positive regulation of interferon-alpha production (GO:0032727) | 2.90666299 |
79 | neutrophil activation involved in immune response (GO:0002283) | 2.87382704 |
80 | regulation of blood coagulation (GO:0030193) | 2.86760631 |
81 | regulation of hemostasis (GO:1900046) | 2.86760631 |
82 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85105857 |
83 | phagocytosis, recognition (GO:0006910) | 2.85022734 |
84 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.84664543 |
85 | plasma lipoprotein particle organization (GO:0071827) | 2.84060614 |
86 | positive regulation of mast cell activation (GO:0033005) | 2.83798702 |
87 | iron ion import (GO:0097286) | 2.82624567 |
88 | cholesterol efflux (GO:0033344) | 2.82482065 |
89 | negative regulation of phagocytosis (GO:0050765) | 2.81754309 |
90 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.81640827 |
91 | lymph vessel development (GO:0001945) | 2.81345447 |
92 | regulation of coagulation (GO:0050818) | 2.81261826 |
93 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.80861085 |
94 | valine metabolic process (GO:0006573) | 2.80527150 |
95 | regulation of interferon-alpha production (GO:0032647) | 2.80209731 |
96 | B cell mediated immunity (GO:0019724) | 2.77874272 |
97 | macrophage activation involved in immune response (GO:0002281) | 2.77336259 |
98 | regulation of mononuclear cell migration (GO:0071675) | 2.76209646 |
99 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.75388700 |
100 | protein-lipid complex subunit organization (GO:0071825) | 2.75356577 |
101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.75289523 |
102 | cholesterol transport (GO:0030301) | 2.74998405 |
103 | sterol transport (GO:0015918) | 2.74998405 |
104 | positive regulation of leukocyte degranulation (GO:0043302) | 2.74310836 |
105 | plasma lipoprotein particle clearance (GO:0034381) | 2.72989579 |
106 | ribosomal small subunit assembly (GO:0000028) | 2.71771194 |
107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.70265527 |
108 | protein carboxylation (GO:0018214) | 2.70265527 |
109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.70014229 |
110 | hepatocyte apoptotic process (GO:0097284) | 2.69700110 |
111 | regulation of complement activation (GO:0030449) | 2.67693518 |
112 | negative regulation of lipid storage (GO:0010888) | 2.66859619 |
113 | positive regulation of wound healing (GO:0090303) | 2.65911730 |
114 | positive regulation of receptor recycling (GO:0001921) | 2.64619510 |
115 | low-density lipoprotein particle clearance (GO:0034383) | 2.64539834 |
116 | mesodermal cell differentiation (GO:0048333) | 2.63187180 |
117 | cyclooxygenase pathway (GO:0019371) | 2.61511073 |
118 | negative regulation of protein activation cascade (GO:2000258) | 2.60687134 |
119 | negative regulation of complement activation (GO:0045916) | 2.60341446 |
120 | surfactant homeostasis (GO:0043129) | 2.59716931 |
121 | phagocytosis, engulfment (GO:0006911) | 2.59579125 |
122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.59171772 |
123 | epithelial cilium movement (GO:0003351) | 2.58994398 |
124 | extracellular fibril organization (GO:0043206) | 2.58785068 |
125 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57710940 |
126 | response to host immune response (GO:0052572) | 2.57710940 |
127 | regulation of protein activation cascade (GO:2000257) | 2.55771666 |
128 | response to interferon-alpha (GO:0035455) | 2.54720209 |
129 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.54534723 |
130 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.53937290 |
131 | negative regulation of wound healing (GO:0061045) | 2.52788084 |
132 | toxin transport (GO:1901998) | 2.52575610 |
133 | ceramide catabolic process (GO:0046514) | 2.52060391 |
134 | membrane invagination (GO:0010324) | 2.51925870 |
135 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.51061603 |
136 | transcytosis (GO:0045056) | 2.49533488 |
137 | macrophage activation (GO:0042116) | 2.49073353 |
138 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48540312 |
139 | regulation of integrin activation (GO:0033623) | 2.47851230 |
140 | blood vessel maturation (GO:0001955) | 2.46813690 |
141 | positive regulation of interferon-beta production (GO:0032728) | 2.46011375 |
142 | endothelial tube morphogenesis (GO:0061154) | 2.45624916 |
143 | morphogenesis of an endothelium (GO:0003159) | 2.45624916 |
144 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45340336 |
145 | response to host (GO:0075136) | 2.45340336 |
146 | response to host defenses (GO:0052200) | 2.45340336 |
147 | regulation of B cell differentiation (GO:0045577) | 2.45168031 |
148 | response to muramyl dipeptide (GO:0032495) | 2.43863268 |
149 | negative regulation of macrophage differentiation (GO:0045650) | 2.41851938 |
150 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40011826 |
151 | ovulation from ovarian follicle (GO:0001542) | 2.39841657 |
152 | response to interferon-beta (GO:0035456) | 2.39157242 |
153 | megakaryocyte development (GO:0035855) | 2.38969102 |
154 | regulation of macrophage differentiation (GO:0045649) | 2.37300767 |
155 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.37031796 |
156 | thrombin receptor signaling pathway (GO:0070493) | 2.35663761 |
157 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.35328447 |
158 | positive regulation of vasculogenesis (GO:2001214) | 2.34215496 |
159 | positive regulation of macrophage differentiation (GO:0045651) | 2.33990824 |
160 | platelet dense granule organization (GO:0060155) | 2.33445043 |
161 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.29255391 |
162 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.28213133 |
163 | mature B cell differentiation involved in immune response (GO:0002313) | 2.27825750 |
164 | execution phase of apoptosis (GO:0097194) | 2.27731612 |
165 | myeloid dendritic cell activation (GO:0001773) | 2.27488018 |
166 | positive regulation of lamellipodium assembly (GO:0010592) | 2.26542733 |
167 | growth hormone receptor signaling pathway (GO:0060396) | 2.23941362 |
168 | detection of molecule of bacterial origin (GO:0032490) | 2.23741673 |
169 | response to hydroperoxide (GO:0033194) | 2.23688564 |
170 | cell adhesion mediated by integrin (GO:0033627) | 2.22467785 |
171 | dendritic cell migration (GO:0036336) | 2.22200007 |
172 | negative regulation of stress fiber assembly (GO:0051497) | 2.20677559 |
173 | germ cell migration (GO:0008354) | 2.20323029 |
174 | microglial cell activation (GO:0001774) | 2.20067992 |
175 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.19935537 |
176 | leukocyte tethering or rolling (GO:0050901) | 2.19540676 |
177 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.16405785 |
178 | positive regulation of lamellipodium organization (GO:1902745) | 2.15618905 |
179 | actin nucleation (GO:0045010) | 2.13616166 |
180 | dendritic cell chemotaxis (GO:0002407) | 2.13353448 |
181 | response to type I interferon (GO:0034340) | 2.13144719 |
182 | response to thyroid hormone (GO:0097066) | 2.13052438 |
183 | response to peptidoglycan (GO:0032494) | 2.12149829 |
184 | peptide catabolic process (GO:0043171) | 2.11618697 |
185 | regulation of antigen processing and presentation (GO:0002577) | 2.10804524 |
186 | apoptotic cell clearance (GO:0043277) | 2.10390449 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.02183310 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80980201 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12017790 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10777524 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04760784 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.01776182 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.01316143 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97265141 |
9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93348551 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85649234 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85637091 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70615678 |
13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70600412 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65945351 |
15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53452257 |
16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.40676175 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19137896 |
18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.18266537 |
19 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.15903735 |
20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.13022851 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12816859 |
22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.09301559 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06512287 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06293925 |
25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06221257 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02217130 |
27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.01683905 |
28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97876304 |
29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.97819677 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96236870 |
31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.95984613 |
32 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.95741517 |
33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95172922 |
34 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93054469 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89729719 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88651740 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76764651 |
38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76208818 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74017067 |
40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73012999 |
41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71822823 |
42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71484584 |
43 | MYB_26560356_Chip-Seq_TH2_Human | 1.70735230 |
44 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.69696599 |
45 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.69696599 |
46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69148319 |
47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67931471 |
48 | MAF_26560356_Chip-Seq_TH1_Human | 1.67824064 |
49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67232766 |
50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66604075 |
51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66301476 |
52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61001759 |
53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59774369 |
54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59428936 |
55 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57028377 |
56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55448137 |
57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54933614 |
58 | MYB_26560356_Chip-Seq_TH1_Human | 1.53642369 |
59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53405037 |
60 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.51368675 |
61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.50664578 |
62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49760453 |
63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48293939 |
64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.47730427 |
65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45820565 |
66 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43399096 |
67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.43083470 |
68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43068628 |
69 | MYC_22102868_ChIP-Seq_BL_Human | 1.41683113 |
70 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41254324 |
71 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40923483 |
72 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40611842 |
73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38926410 |
74 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.38698350 |
75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37012755 |
76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32971301 |
77 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32779139 |
78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31830334 |
79 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30877687 |
80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30646842 |
81 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30355529 |
82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29988905 |
83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27962700 |
84 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27388467 |
85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.25483479 |
86 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22685339 |
87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21917741 |
88 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21818907 |
89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20816705 |
90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20305124 |
91 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19908952 |
92 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19560405 |
93 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19189004 |
94 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18793701 |
95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18750338 |
96 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18143150 |
97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17509320 |
98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17500393 |
99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17133238 |
100 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16093432 |
101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15726108 |
102 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14618252 |
103 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13456112 |
104 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13364692 |
105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12642644 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12330991 |
107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11820852 |
108 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11310044 |
109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11247115 |
110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11247115 |
111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11030927 |
112 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10562184 |
113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08529987 |
114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07366230 |
115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06751832 |
116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05366223 |
117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05163386 |
118 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04633067 |
119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04477367 |
120 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03722990 |
121 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.03475971 |
122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02940141 |
123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02900707 |
124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01166689 |
125 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.00587713 |
126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99984815 |
127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99858329 |
128 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98356648 |
129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97696727 |
130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97384327 |
131 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97352671 |
132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96198502 |
133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95752912 |
134 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.94792284 |
135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93384390 |
136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93158148 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003950_abnormal_plasma_membrane | 3.37435189 |
2 | MP0001835_abnormal_antigen_presentation | 2.89769458 |
3 | MP0010368_abnormal_lymphatic_system | 2.54684857 |
4 | MP0002396_abnormal_hematopoietic_system | 2.38349116 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.37717044 |
6 | MP0005365_abnormal_bile_salt | 2.35381393 |
7 | MP0003300_gastrointestinal_ulcer | 2.23678689 |
8 | MP0003724_increased_susceptibility_to | 2.21035546 |
9 | MP0002139_abnormal_hepatobiliary_system | 2.19265353 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.13283560 |
11 | MP0002132_abnormal_respiratory_system | 2.08846189 |
12 | MP0009780_abnormal_chondrocyte_physiolo | 2.07557432 |
13 | MP0001879_abnormal_lymphatic_vessel | 2.07532989 |
14 | MP0003828_pulmonary_edema | 1.99912544 |
15 | MP0003436_decreased_susceptibility_to | 1.97927361 |
16 | MP0009278_abnormal_bone_marrow | 1.94629844 |
17 | MP0005360_urolithiasis | 1.88727068 |
18 | MP0006054_spinal_hemorrhage | 1.88039502 |
19 | MP0009785_altered_susceptibility_to | 1.87765287 |
20 | MP0002419_abnormal_innate_immunity | 1.86583222 |
21 | MP0003656_abnormal_erythrocyte_physiolo | 1.86272308 |
22 | MP0001853_heart_inflammation | 1.85110524 |
23 | MP0004808_abnormal_hematopoietic_stem | 1.82875420 |
24 | MP0005671_abnormal_response_to | 1.78282076 |
25 | MP0005058_abnormal_lysosome_morphology | 1.76654950 |
26 | MP0005397_hematopoietic_system_phenotyp | 1.74159654 |
27 | MP0001545_abnormal_hematopoietic_system | 1.74159654 |
28 | MP0005167_abnormal_blood-brain_barrier | 1.72532838 |
29 | MP0002877_abnormal_melanocyte_morpholog | 1.71868377 |
30 | MP0002166_altered_tumor_susceptibility | 1.70926697 |
31 | MP0009840_abnormal_foam_cell | 1.70608683 |
32 | MP0002452_abnormal_antigen_presenting | 1.68458822 |
33 | MP0000343_altered_response_to | 1.67668664 |
34 | MP0001873_stomach_inflammation | 1.67538114 |
35 | MP0005464_abnormal_platelet_physiology | 1.65916310 |
36 | MP0005085_abnormal_gallbladder_physiolo | 1.65618694 |
37 | MP0000685_abnormal_immune_system | 1.64946992 |
38 | MP0005025_abnormal_response_to | 1.64680508 |
39 | MP0001800_abnormal_humoral_immune | 1.61748787 |
40 | MP0003705_abnormal_hypodermis_morpholog | 1.61259155 |
41 | MP0002148_abnormal_hypersensitivity_rea | 1.59625059 |
42 | MP0003718_maternal_effect | 1.56607359 |
43 | MP0003303_peritoneal_inflammation | 1.56270902 |
44 | MP0010155_abnormal_intestine_physiology | 1.53924332 |
45 | MP0005000_abnormal_immune_tolerance | 1.52566411 |
46 | MP0001819_abnormal_immune_cell | 1.48264326 |
47 | MP0005165_increased_susceptibility_to | 1.48037446 |
48 | MP0002420_abnormal_adaptive_immunity | 1.47949802 |
49 | MP0002723_abnormal_immune_serum | 1.40819479 |
50 | MP0002405_respiratory_system_inflammati | 1.40658734 |
51 | MP0000465_gastrointestinal_hemorrhage | 1.40640309 |
52 | MP0003566_abnormal_cell_adhesion | 1.40336027 |
53 | MP0004272_abnormal_basement_membrane | 1.38714457 |
54 | MP0005387_immune_system_phenotype | 1.36654484 |
55 | MP0001790_abnormal_immune_system | 1.36654484 |
56 | MP0004147_increased_porphyrin_level | 1.35289332 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.34334435 |
58 | MP0003091_abnormal_cell_migration | 1.30186995 |
59 | MP0001845_abnormal_inflammatory_respons | 1.28892148 |
60 | MP0003075_altered_response_to | 1.28442371 |
61 | MP0001533_abnormal_skeleton_physiology | 1.27892830 |
62 | MP0002006_tumorigenesis | 1.24716104 |
63 | MP0004947_skin_inflammation | 1.24248720 |
64 | MP0002138_abnormal_hepatobiliary_system | 1.20275434 |
65 | MP0002398_abnormal_bone_marrow | 1.20119479 |
66 | MP0003448_altered_tumor_morphology | 1.19560730 |
67 | MP0003279_aneurysm | 1.19490297 |
68 | MP0002254_reproductive_system_inflammat | 1.19367239 |
69 | MP0009333_abnormal_splenocyte_physiolog | 1.19115980 |
70 | MP0010307_abnormal_tumor_latency | 1.16304681 |
71 | MP0008469_abnormal_protein_level | 1.15934025 |
72 | MP0000689_abnormal_spleen_morphology | 1.14157290 |
73 | MP0005395_other_phenotype | 1.12995526 |
74 | MP0003806_abnormal_nucleotide_metabolis | 1.12485546 |
75 | MP0000716_abnormal_immune_system | 1.11016076 |
76 | MP0002722_abnormal_immune_system | 1.08968006 |
77 | MP0005408_hypopigmentation | 1.08497391 |
78 | MP0003943_abnormal_hepatobiliary_system | 1.07775209 |
79 | MP0000249_abnormal_blood_vessel | 1.06895314 |
80 | MP0009764_decreased_sensitivity_to | 1.05955969 |
81 | MP0000490_abnormal_crypts_of | 1.05045298 |
82 | MP0003453_abnormal_keratinocyte_physiol | 1.04559630 |
83 | MP0002136_abnormal_kidney_physiology | 1.04249519 |
84 | MP0003172_abnormal_lysosome_physiology | 1.04068139 |
85 | MP0002429_abnormal_blood_cell | 1.03233108 |
86 | MP0006082_CNS_inflammation | 1.01733519 |
87 | MP0001958_emphysema | 1.00077470 |
88 | MP0003195_calcinosis | 0.98625483 |
89 | MP0010329_abnormal_lipoprotein_level | 0.97456175 |
90 | MP0003868_abnormal_feces_composition | 0.96990956 |
91 | MP0008438_abnormal_cutaneous_collagen | 0.95540116 |
92 | MP0000767_abnormal_smooth_muscle | 0.95534745 |
93 | MP0005670_abnormal_white_adipose | 0.95292332 |
94 | MP0000858_altered_metastatic_potential | 0.94468152 |
95 | MP0009643_abnormal_urine_homeostasis | 0.93954998 |
96 | MP0002896_abnormal_bone_mineralization | 0.93396255 |
97 | MP0010678_abnormal_skin_adnexa | 0.93246971 |
98 | MP0004084_abnormal_cardiac_muscle | 0.91890761 |
99 | MP0003866_abnormal_defecation | 0.90637317 |
100 | MP0004782_abnormal_surfactant_physiolog | 0.90479895 |
101 | MP0003763_abnormal_thymus_physiology | 0.88971213 |
102 | MP0001915_intracranial_hemorrhage | 0.88922123 |
103 | MP0005410_abnormal_fertilization | 0.88806996 |
104 | MP0005083_abnormal_biliary_tract | 0.88760957 |
105 | MP0005409_darkened_coat_color | 0.87654115 |
106 | MP0000604_amyloidosis | 0.87186510 |
107 | MP0002998_abnormal_bone_remodeling | 0.84029059 |
108 | MP0009763_increased_sensitivity_to | 0.83925502 |
109 | MP0005451_abnormal_body_composition | 0.83071209 |
110 | MP0000609_abnormal_liver_physiology | 0.82685936 |
111 | MP0001756_abnormal_urination | 0.81766654 |
112 | MP0000569_abnormal_digit_pigmentation | 0.81356036 |
113 | MP0002168_other_aberrant_phenotype | 0.80748106 |
114 | MP0001666_abnormal_nutrient_absorption | 0.80639548 |
115 | MP0008007_abnormal_cellular_replicative | 0.80460205 |
116 | MP0010234_abnormal_vibrissa_follicle | 0.79834766 |
117 | MP0005257_abnormal_intraocular_pressure | 0.79666593 |
118 | MP0001542_abnormal_bone_strength | 0.78823835 |
119 | MP0004883_abnormal_blood_vessel | 0.77971349 |
120 | MP0009697_abnormal_copulation | 0.77512734 |
121 | MP0001663_abnormal_digestive_system | 0.77361066 |
122 | MP0003183_abnormal_peptide_metabolism | 0.76169361 |
123 | MP0005164_abnormal_response_to | 0.75847696 |
124 | MP0004019_abnormal_vitamin_homeostasis | 0.75735205 |
125 | MP0008004_abnormal_stomach_pH | 0.75605061 |
126 | MP0005166_decreased_susceptibility_to | 0.75165914 |
127 | MP0005023_abnormal_wound_healing | 0.73716015 |
128 | MP0002009_preneoplasia | 0.73126114 |
129 | MP0003252_abnormal_bile_duct | 0.73102447 |
130 | MP0004130_abnormal_muscle_cell | 0.72984012 |
131 | MP0004510_myositis | 0.72895083 |
132 | MP0000598_abnormal_liver_morphology | 0.72694311 |
133 | MP0009115_abnormal_fat_cell | 0.72426765 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.04967578 |
2 | Abnormal ciliary motility (HP:0012262) | 4.99047649 |
3 | Absent/shortened dynein arms (HP:0200106) | 4.93594509 |
4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.93594509 |
5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.85855132 |
6 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.85855132 |
7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.81854198 |
8 | Rhinitis (HP:0012384) | 4.61141325 |
9 | Recurrent abscess formation (HP:0002722) | 3.72405438 |
10 | Vacuolated lymphocytes (HP:0001922) | 3.69247961 |
11 | Systemic lupus erythematosus (HP:0002725) | 3.61098470 |
12 | Spontaneous hematomas (HP:0007420) | 3.47808946 |
13 | Myositis (HP:0100614) | 3.46210217 |
14 | Hematochezia (HP:0002573) | 3.44968955 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.43450978 |
16 | Recurrent bacterial skin infections (HP:0005406) | 3.35632740 |
17 | Male infertility (HP:0003251) | 3.32124357 |
18 | Bronchiectasis (HP:0002110) | 3.19745619 |
19 | Glomerulonephritis (HP:0000099) | 3.14077728 |
20 | Eczematoid dermatitis (HP:0000976) | 3.09862611 |
21 | Acanthocytosis (HP:0001927) | 3.06346431 |
22 | Chronic bronchitis (HP:0004469) | 2.98734261 |
23 | Xanthomatosis (HP:0000991) | 2.97893990 |
24 | Increased cerebral lipofuscin (HP:0011813) | 2.93259082 |
25 | Orchitis (HP:0100796) | 2.91216193 |
26 | Prolonged bleeding time (HP:0003010) | 2.87879304 |
27 | Syringomyelia (HP:0003396) | 2.86392199 |
28 | Spinal cord lesions (HP:0100561) | 2.86392199 |
29 | Thrombocytosis (HP:0001894) | 2.86074825 |
30 | Deep venous thrombosis (HP:0002625) | 2.79409665 |
31 | Hyperlipoproteinemia (HP:0010980) | 2.79133224 |
32 | Conjunctival telangiectasia (HP:0000524) | 2.78815308 |
33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78010771 |
34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78010771 |
35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78010771 |
36 | IgM deficiency (HP:0002850) | 2.75692246 |
37 | Nephritis (HP:0000123) | 2.73944875 |
38 | Abnormality of macrophages (HP:0004311) | 2.71720253 |
39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71345977 |
40 | Petechiae (HP:0000967) | 2.69613741 |
41 | Osteolytic defects of the hand bones (HP:0009699) | 2.67747066 |
42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.67747066 |
43 | Mitral stenosis (HP:0001718) | 2.65511200 |
44 | Pustule (HP:0200039) | 2.61041637 |
45 | Abnormality of complement system (HP:0005339) | 2.60395607 |
46 | Abnormal platelet function (HP:0011869) | 2.60312616 |
47 | Impaired platelet aggregation (HP:0003540) | 2.60312616 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.58987887 |
49 | Autoimmune thrombocytopenia (HP:0001973) | 2.58005601 |
50 | Abnormal platelet volume (HP:0011876) | 2.57974871 |
51 | Papillary thyroid carcinoma (HP:0002895) | 2.56802302 |
52 | Chronic otitis media (HP:0000389) | 2.53842146 |
53 | Recurrent viral infections (HP:0004429) | 2.52237392 |
54 | Complement deficiency (HP:0004431) | 2.50669298 |
55 | Vascular calcification (HP:0004934) | 2.49265836 |
56 | Colitis (HP:0002583) | 2.49140419 |
57 | Abnormality of the nasal mucosa (HP:0000433) | 2.48466690 |
58 | Cerebral aneurysm (HP:0004944) | 2.48265157 |
59 | Metaphyseal irregularity (HP:0003025) | 2.47403059 |
60 | Cardiovascular calcification (HP:0011915) | 2.45716199 |
61 | Prostate neoplasm (HP:0100787) | 2.45449224 |
62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44691187 |
63 | Recurrent fungal infections (HP:0002841) | 2.44584585 |
64 | Infertility (HP:0000789) | 2.44528572 |
65 | Increased mean platelet volume (HP:0011877) | 2.43771731 |
66 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.42436612 |
67 | Recurrent sinusitis (HP:0011108) | 2.37394897 |
68 | Arterial thrombosis (HP:0004420) | 2.34699381 |
69 | Cellulitis (HP:0100658) | 2.33182634 |
70 | Optic neuritis (HP:0100653) | 2.31051840 |
71 | Retrobulbar optic neuritis (HP:0100654) | 2.31051840 |
72 | Disinhibition (HP:0000734) | 2.28158856 |
73 | Nausea (HP:0002018) | 2.27630948 |
74 | Myocardial infarction (HP:0001658) | 2.27392361 |
75 | Aortic aneurysm (HP:0004942) | 2.26557435 |
76 | Congenital, generalized hypertrichosis (HP:0004540) | 2.23155269 |
77 | Flat acetabular roof (HP:0003180) | 2.21400315 |
78 | Mesangial abnormality (HP:0001966) | 2.21250154 |
79 | Dysostosis multiplex (HP:0000943) | 2.20319540 |
80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19832213 |
81 | Inflammation of the large intestine (HP:0002037) | 2.17883288 |
82 | Fat malabsorption (HP:0002630) | 2.16192995 |
83 | Mediastinal lymphadenopathy (HP:0100721) | 2.16059299 |
84 | Arterial tortuosity (HP:0005116) | 2.15528716 |
85 | Facial diplegia (HP:0001349) | 2.13679957 |
86 | Esophageal varix (HP:0002040) | 2.12415046 |
87 | Gastrointestinal inflammation (HP:0004386) | 2.11669134 |
88 | Subacute progressive viral hepatitis (HP:0006572) | 2.10304701 |
89 | Hemorrhage of the eye (HP:0011885) | 2.08655075 |
90 | Vascular tortuosity (HP:0004948) | 2.07708101 |
91 | Hepatosplenomegaly (HP:0001433) | 2.07523542 |
92 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.07379249 |
93 | Joint hemorrhage (HP:0005261) | 2.05832509 |
94 | Polycythemia (HP:0001901) | 2.05296291 |
95 | Acute myeloid leukemia (HP:0004808) | 2.05158534 |
96 | Abnormality of the prostate (HP:0008775) | 2.05046126 |
97 | Bruising susceptibility (HP:0000978) | 2.03906506 |
98 | Hypophosphatemic rickets (HP:0004912) | 2.01039274 |
99 | Poikilocytosis (HP:0004447) | 1.99786478 |
100 | Abnormality of carpal bone ossification (HP:0006257) | 1.99233905 |
101 | Periodontitis (HP:0000704) | 1.99171778 |
102 | Mucosal telangiectasiae (HP:0100579) | 1.98106332 |
103 | Epistaxis (HP:0000421) | 1.96475298 |
104 | Recurrent skin infections (HP:0001581) | 1.94681965 |
105 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90214643 |
106 | Keratoconjunctivitis sicca (HP:0001097) | 1.89859435 |
107 | Hypoproteinemia (HP:0003075) | 1.89588677 |
108 | Thyroiditis (HP:0100646) | 1.88887825 |
109 | Hypercholesterolemia (HP:0003124) | 1.88639637 |
110 | Steatorrhea (HP:0002570) | 1.88050063 |
111 | Conjugated hyperbilirubinemia (HP:0002908) | 1.87963091 |
112 | Abnormality of the acetabulum (HP:0003170) | 1.87569688 |
113 | Mucopolysacchariduria (HP:0008155) | 1.85954273 |
114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85954273 |
115 | Viral hepatitis (HP:0006562) | 1.85257830 |
116 | Tetraparesis (HP:0002273) | 1.84940160 |
117 | Nasal polyposis (HP:0100582) | 1.84014736 |
118 | Chronic sinusitis (HP:0011109) | 1.82957825 |
119 | Gingivitis (HP:0000230) | 1.81518603 |
120 | Keratoconjunctivitis (HP:0001096) | 1.81475203 |
121 | Thick nail (HP:0001805) | 1.81053787 |
122 | Purpura (HP:0000979) | 1.80683180 |
123 | Menorrhagia (HP:0000132) | 1.79698459 |
124 | Abnormality of proline metabolism (HP:0010907) | 1.79575263 |
125 | Hydroxyprolinuria (HP:0003080) | 1.79575263 |
126 | Encephalitis (HP:0002383) | 1.79368210 |
127 | Skin nodule (HP:0200036) | 1.77631595 |
128 | Panhypogammaglobulinemia (HP:0003139) | 1.77264206 |
129 | Hypertriglyceridemia (HP:0002155) | 1.76098988 |
130 | Gingival bleeding (HP:0000225) | 1.75895992 |
131 | Recurrent otitis media (HP:0000403) | 1.73794514 |
132 | Bronchitis (HP:0012387) | 1.73564092 |
133 | Osteomyelitis (HP:0002754) | 1.73016343 |
134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72922245 |
135 | Obstructive lung disease (HP:0006536) | 1.72922245 |
136 | Aortic dissection (HP:0002647) | 1.72724442 |
137 | Hyperglycinuria (HP:0003108) | 1.72692290 |
138 | Increased IgE level (HP:0003212) | 1.71045298 |
139 | Increased serum ferritin (HP:0003281) | 1.70637823 |
140 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70566077 |
141 | Meningitis (HP:0001287) | 1.70461822 |
142 | Axonal loss (HP:0003447) | 1.70369876 |
143 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.69575753 |
144 | Distal lower limb muscle weakness (HP:0009053) | 1.69360513 |
145 | Glucose intolerance (HP:0000833) | 1.69316228 |
146 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69268902 |
147 | Abnormality of iron homeostasis (HP:0011031) | 1.69146008 |
148 | Protrusio acetabuli (HP:0003179) | 1.68876447 |
149 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68743634 |
150 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68743634 |
151 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68743634 |
152 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.67924907 |
153 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64261395 |
154 | Premature rupture of membranes (HP:0001788) | 1.63243292 |
155 | Upper limb muscle weakness (HP:0003484) | 1.63242530 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 3.43555089 |
2 | TGFBR2 | 3.40888903 |
3 | KDR | 3.04688046 |
4 | EIF2AK1 | 2.64070816 |
5 | TYK2 | 2.53059232 |
6 | RIPK4 | 2.35597594 |
7 | BMPR2 | 2.32492023 |
8 | MAP4K1 | 2.28619865 |
9 | MAP3K14 | 2.24983224 |
10 | KIT | 2.17949790 |
11 | TGFBR1 | 2.08454746 |
12 | MAP3K12 | 2.08071903 |
13 | IRAK3 | 2.07400872 |
14 | IRAK4 | 1.85043847 |
15 | EPHA2 | 1.83644893 |
16 | STK10 | 1.82226017 |
17 | TBK1 | 1.80720133 |
18 | ACVR1B | 1.75246912 |
19 | TEC | 1.70202087 |
20 | NME2 | 1.68296787 |
21 | LRRK2 | 1.67330914 |
22 | STK39 | 1.67030868 |
23 | PKN2 | 1.60676566 |
24 | MET | 1.59499258 |
25 | NEK9 | 1.59172958 |
26 | BTK | 1.57674746 |
27 | BMX | 1.55919261 |
28 | JAK3 | 1.54192298 |
29 | TRIB3 | 1.51972476 |
30 | PIM2 | 1.50930036 |
31 | ERN1 | 1.50491532 |
32 | EEF2K | 1.49835626 |
33 | JAK1 | 1.45531354 |
34 | PDK2 | 1.44330922 |
35 | MAP2K3 | 1.43043968 |
36 | MAP3K13 | 1.39367087 |
37 | FRK | 1.38353057 |
38 | PTK2B | 1.37844531 |
39 | RIPK1 | 1.37427971 |
40 | ZAP70 | 1.37202671 |
41 | PTK6 | 1.34232416 |
42 | ERBB4 | 1.34125585 |
43 | NUAK1 | 1.33806203 |
44 | TXK | 1.33753602 |
45 | EPHB1 | 1.29651933 |
46 | MAPK15 | 1.29126675 |
47 | IKBKE | 1.28605406 |
48 | BLK | 1.27867334 |
49 | CSF1R | 1.25336985 |
50 | FER | 1.23886364 |
51 | FLT3 | 1.23390340 |
52 | FGFR3 | 1.22635106 |
53 | TRPM7 | 1.21683793 |
54 | CHUK | 1.20890429 |
55 | FGFR4 | 1.20354963 |
56 | ARAF | 1.19592396 |
57 | MST4 | 1.17534853 |
58 | TAOK3 | 1.17030046 |
59 | SCYL2 | 1.15542875 |
60 | CDK6 | 1.15004141 |
61 | AKT3 | 1.12984326 |
62 | PIM1 | 1.11047006 |
63 | FGR | 1.09361551 |
64 | PBK | 1.07978766 |
65 | MAPKAPK3 | 1.07562187 |
66 | IKBKB | 1.06918922 |
67 | ITK | 1.06796370 |
68 | MAP3K2 | 1.06118539 |
69 | CAMKK2 | 1.05339802 |
70 | EIF2AK3 | 1.05291045 |
71 | MAP3K10 | 1.02859731 |
72 | TTN | 1.02808390 |
73 | MST1R | 1.02206260 |
74 | PAK4 | 0.98459393 |
75 | DDR2 | 0.96411928 |
76 | MYLK | 0.96221572 |
77 | MOS | 0.93210381 |
78 | RPS6KA4 | 0.89456172 |
79 | PDPK1 | 0.88340848 |
80 | MAP3K3 | 0.86885164 |
81 | STK3 | 0.86100727 |
82 | CSK | 0.85516106 |
83 | BRSK2 | 0.83431732 |
84 | JAK2 | 0.83077639 |
85 | PRKG2 | 0.82596421 |
86 | WNK4 | 0.79584484 |
87 | MATK | 0.78782590 |
88 | DYRK1B | 0.78062021 |
89 | PIK3CG | 0.77135519 |
90 | CAMK1D | 0.76613852 |
91 | MELK | 0.76401120 |
92 | EIF2AK2 | 0.75299451 |
93 | NEK2 | 0.74086710 |
94 | CDK8 | 0.74032372 |
95 | STK24 | 0.73526924 |
96 | MARK3 | 0.72263006 |
97 | NEK6 | 0.72162505 |
98 | LCK | 0.72074888 |
99 | SYK | 0.69307379 |
100 | LYN | 0.68679672 |
101 | PTK2 | 0.68043458 |
102 | SIK1 | 0.65072093 |
103 | PDK1 | 0.64275592 |
104 | HCK | 0.64248363 |
105 | CDK9 | 0.62188451 |
106 | BCR | 0.60277868 |
107 | PAK1 | 0.59949281 |
108 | PDGFRA | 0.57996717 |
109 | MAP3K5 | 0.57940714 |
110 | PRKAA2 | 0.57239657 |
111 | ABL2 | 0.56644278 |
112 | ERBB3 | 0.55531621 |
113 | INSRR | 0.55418513 |
114 | GRK1 | 0.55025927 |
115 | CCNB1 | 0.52942137 |
116 | MAP3K8 | 0.52897953 |
117 | MAPK11 | 0.51671358 |
118 | GRK7 | 0.51105780 |
119 | LIMK1 | 0.50980620 |
120 | ABL1 | 0.50266768 |
121 | WEE1 | 0.49891218 |
122 | IGF1R | 0.49604035 |
123 | TSSK6 | 0.49420093 |
124 | CDK4 | 0.49322939 |
125 | RET | 0.49058178 |
126 | RAF1 | 0.49002797 |
127 | STK4 | 0.48013035 |
128 | EPHB2 | 0.47386668 |
129 | PAK2 | 0.46582801 |
130 | NLK | 0.45555523 |
131 | FGFR1 | 0.45505313 |
132 | ROCK1 | 0.44007209 |
133 | YES1 | 0.43844495 |
134 | LMTK2 | 0.43672546 |
135 | MAPKAPK2 | 0.43025804 |
136 | EPHA3 | 0.42170227 |
137 | TTK | 0.42138557 |
138 | EGFR | 0.40429630 |
139 | LATS1 | 0.40062991 |
140 | PDGFRB | 0.39893162 |
141 | MAPK4 | 0.39604171 |
142 | ICK | 0.39391552 |
143 | ZAK | 0.39059454 |
144 | ILK | 0.39046638 |
145 | AURKB | 0.38354088 |
146 | DMPK | 0.38309800 |
147 | CDC42BPA | 0.37352199 |
148 | TNIK | 0.36567447 |
149 | ERBB2 | 0.35344794 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70323862 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18634561 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87371303 |
4 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.85058318 |
5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.84126689 |
6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.81098664 |
7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77709150 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77585876 |
9 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75861624 |
10 | Pertussis_Homo sapiens_hsa05133 | 1.72310668 |
11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70464311 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66300456 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66291433 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64542126 |
15 | Measles_Homo sapiens_hsa05162 | 1.61290224 |
16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61047335 |
17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.59376448 |
18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.59150844 |
19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57996802 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.57015480 |
21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56792891 |
22 | Lysosome_Homo sapiens_hsa04142 | 1.54876359 |
23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54345411 |
24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48767223 |
25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48706501 |
26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.47598623 |
27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44460693 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43401199 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43258821 |
30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.42881523 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41862506 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41533790 |
33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41205613 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40434583 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37803950 |
36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37485331 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31889880 |
38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31613409 |
39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28194938 |
40 | Malaria_Homo sapiens_hsa05144 | 1.26974516 |
41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24255733 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.19263164 |
43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.18379224 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18005030 |
45 | Platelet activation_Homo sapiens_hsa04611 | 1.14516551 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.14244304 |
47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13127265 |
48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12334447 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 1.11379233 |
50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10311546 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09732235 |
52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09197240 |
53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06163961 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05680397 |
55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.03570611 |
56 | Shigellosis_Homo sapiens_hsa05131 | 1.03243829 |
57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.02502373 |
58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01356180 |
59 | Ribosome_Homo sapiens_hsa03010 | 0.99888645 |
60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98893398 |
61 | Focal adhesion_Homo sapiens_hsa04510 | 0.98387486 |
62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96807079 |
63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96748053 |
64 | Hepatitis B_Homo sapiens_hsa05161 | 0.95126112 |
65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94638916 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94597948 |
67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93800168 |
68 | Salmonella infection_Homo sapiens_hsa05132 | 0.93503091 |
69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93142032 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.91711196 |
71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91564340 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91401910 |
73 | Endocytosis_Homo sapiens_hsa04144 | 0.88649531 |
74 | ABC transporters_Homo sapiens_hsa02010 | 0.87967805 |
75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87528783 |
76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87200303 |
77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86948448 |
78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85803138 |
79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85656555 |
80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85252106 |
81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84203133 |
82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81800369 |
83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79407179 |
84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79248502 |
85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78441960 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78195343 |
87 | Insulin resistance_Homo sapiens_hsa04931 | 0.77554189 |
88 | Adherens junction_Homo sapiens_hsa04520 | 0.77499726 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.75699548 |
90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.75425972 |
91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74975591 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74670421 |
93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72347462 |
94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71888909 |
95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71182927 |
96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70882377 |
97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70024572 |
98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69932002 |
99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68453771 |
100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68032232 |
101 | Allograft rejection_Homo sapiens_hsa05330 | 0.67709130 |
102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66291431 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64925977 |
104 | Asthma_Homo sapiens_hsa05310 | 0.64543417 |
105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64167900 |
106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63258616 |
107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62495863 |
108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61954639 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57402711 |
110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56341829 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55823383 |
112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55405312 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.55399957 |
114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53689091 |
115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53669053 |
116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53438825 |
117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53262231 |
118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52869939 |
119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52468332 |
120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50845555 |
121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50745639 |
122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49212693 |
123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48410531 |
124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48403970 |
125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47810711 |
126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46875178 |
127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46465178 |
128 | Phagosome_Homo sapiens_hsa04145 | 0.46149528 |
129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45763474 |
130 | Cell cycle_Homo sapiens_hsa04110 | 0.45553982 |
131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44036327 |
132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43669278 |
133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43454733 |
134 | Mineral absorption_Homo sapiens_hsa04978 | 0.42639993 |
135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39939604 |
136 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38793144 |
137 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38600774 |